Neuraminidase inhibitors including Tamiflu and Relenza are recommended by government health agencies for treating and preventing symptoms of the influenza virus in both children and adults. A review conducted by the Cochrane Collaboration has now revealed these treatment options may cause more harmful side effects compared to their ability to reduce and prevent flu-like symptoms. “We…
